{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:56:02Z","timestamp":1780523762507,"version":"3.54.1"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40290-022-00420-4","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T05:02:24Z","timestamp":1646370144000},"page":"99-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4384-9210","authenticated-orcid":false,"given":"Gerhard","family":"Nahler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"420_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12231-016-9351-1","volume":"70","author":"HE Jiang","year":"2016","unstructured":"Jiang HE, Wang L, Merlin MD, et al. Ancient Cannabis burial shroud in a central Eurasian cemetery. Econ Bot. 2016;70:213\u201321.","journal-title":"Econ Bot"},{"key":"420_CR2","unstructured":"Liesowska, A. 2014. Iconic 2,500 year old Siberian princess \u2018died from breast cancer\u2019, reveals MRI scan. The Siberian Times. 14 October 2014. Available at: https:\/\/siberiantimes.com\/science\/casestudy\/features\/iconic-2500-year-old-siberian-princess-died-from-breast-cancer-reveals-unique-mri-scan\/. Accessed 28 Jan 2022."},{"issue":"3","key":"420_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/jnci\/55.3.597","volume":"55","author":"AE Munson","year":"1975","unstructured":"Munson AE, Harris LS, Friedman MA, et al. Antineoplastic activity of cannabinoids. J Natl Cancer Inst. 1975;55(3):597\u2013602.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"420_CR4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1124\/jpet.103.061002","volume":"308","author":"P Massi","year":"2004","unstructured":"Massi P, Vaccani A, Ceruti S, et al. Antitumor effects of cannabidiol, a non-psychoactive cannabinoid, on human glioma cell lines. J Pharmacol Exp Ther. 2004;308(3):838\u201345. https:\/\/doi.org\/10.1124\/jpet.103.061002.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"420_CR5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1124\/jpet.106.105247","volume":"318","author":"A Ligresti","year":"2006","unstructured":"Ligresti A, Moriello AS, Starowicz K, et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther. 2006;318(3):1375\u201387. https:\/\/doi.org\/10.1124\/jpet.106.105247.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"420_CR6","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1158\/1535-7163.MCT-07-0371","volume":"6","author":"SD McAllister","year":"2007","unstructured":"McAllister SD, Christian RT, Horowitz MP, et al. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Mol Cancer Ther. 2007;6(11):2921\u20137. https:\/\/doi.org\/10.1158\/1535-7163.MCT-07-0371.","journal-title":"Mol Cancer Ther"},{"key":"420_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1055\/a-0758-8908","volume":"50","author":"F Grotenhermen","year":"2018","unstructured":"Grotenhermen F. Canabis bei Krebs: Mehr Chancen als Risiken? Cannabis in cancer: more opportunities than risks? Deutsche Zeitschrift f\u00fcr Onkologie. 2018;50:188\u201392. https:\/\/doi.org\/10.1055\/a-0758-8908.","journal-title":"Deutsche Zeitschrift f\u00fcr Onkologie"},{"issue":"2","key":"420_CR8","doi-asserted-by":"publisher","first-page":"e0228909","DOI":"10.1371\/journal.pone.0228909","volume":"15","author":"L Milian","year":"2020","unstructured":"Milian L, Mata M, Alcacer J, et al. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro. PLoS ONE. 2020;15(2):e0228909. https:\/\/doi.org\/10.1371\/journal.pone.0228909.","journal-title":"PLoS ONE"},{"key":"420_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1476-5381.2012.02027.x","volume":"168","author":"L De Petrocellis","year":"2013","unstructured":"De Petrocellis L, Ligresti A, Schiano Moriello A, et al. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. Br J Pharmacol. 2013;168:79\u2013102. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02027.x.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"420_CR10","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/ph14111169","volume":"14","author":"H Hamad","year":"2021","unstructured":"Hamad H, Olsen BB. 2021 Cannabidiol induces cell death in human lung cancer cells and cancer stem cells. Pharmaceuticals. 2021;14(11):1169. https:\/\/doi.org\/10.3390\/ph14111169.","journal-title":"Pharmaceuticals"},{"key":"420_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000510256","volume":"3","author":"WM Raup-Konsavage","year":"2020","unstructured":"Raup-Konsavage WM, Carkaci-Salli N, Greenland K, et al. Cannabidiol (CBD) oil does not display an entourage effect in reducing cancer cell viability in vitro. Med Cannabis Cannabinoids. 2020;3:95\u2013102. https:\/\/doi.org\/10.1159\/000510256.","journal-title":"Med Cannabis Cannabinoids"},{"key":"420_CR12","doi-asserted-by":"publisher","first-page":"22494","DOI":"10.1038\/s41598-021-01975-z","volume":"11","author":"C Russo","year":"2021","unstructured":"Russo C, Lavorgna M, Nugnes R, Orlo E, Isidori M. Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin. Sci Rep. 2021;11:22494. https:\/\/doi.org\/10.1038\/s41598-021-01975-z.","journal-title":"Sci Rep"},{"key":"420_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s13104-020-05229-5","volume":"13","author":"A Sainz-Cort","year":"2020","unstructured":"Sainz-Cort A, Muller-Sanchez C, Espel E. Anti-proliferative and cytotoxic effect of cannabidiol on human cancer cell lines in presence of serum. BMC Res Notes. 2020;13:389. https:\/\/doi.org\/10.1186\/s13104-020-05229-5.","journal-title":"BMC Res Notes"},{"issue":"1","key":"420_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bcpt.13152","volume":"124","author":"P Damkier","year":"2019","unstructured":"Damkier P, Lassen D, Hougaard Christensen MM, et al. Interaction between warfarin and cannabis. Basic Clin Pharmacol Toxicol. 2019;124(1):28\u201331. https:\/\/doi.org\/10.1111\/bcpt.13152.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"420_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.725136","volume":"12","author":"C Gross","year":"2021","unstructured":"Gross C, Ramirez DA, McGrath S, Gustafson DL. Cannabidiol induces apoptosis and perturbs mitochondrial function in human and canine glioma cells. Front Pharmacol. 2021;12: 725136. https:\/\/doi.org\/10.3389\/fphar.2021.725136.","journal-title":"Front Pharmacol"},{"key":"420_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/cells10020340","volume":"10","author":"TT Lah","year":"2021","unstructured":"Lah TT, Novak M, Almidon MAP, et al. Cannabigerol is a potential therapeutic agent in a novel combined therapy for glioblastoma. Cells. 2021;10:340. https:\/\/doi.org\/10.3390\/cells10020340.","journal-title":"Cells"},{"issue":"1","key":"420_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1158\/1535-7163.MCT-09-0407","volume":"9","author":"JP Marcu","year":"2010","unstructured":"Marcu JP, Christian RT, Lau D, et al. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Mol Cancer Ther. 2010;9(1):180\u20139. https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0407.","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"420_CR18","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-14-0402","volume":"13","author":"KA Scott","year":"2014","unstructured":"Scott KA, Dalgleish AG, Liu WM. The combination of cannabidiol and D9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model. Mol Cancer Ther. 2014;13(12):2955\u201367. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0402.","journal-title":"Mol Cancer Ther"},{"issue":"Suppl 2","key":"420_CR19","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.3747\/co.23.2893","volume":"23","author":"Z Fisher","year":"2016","unstructured":"Fisher Z, Golan H, Schiby G, et al. In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma. Curr Oncol. 2016;23(Suppl 2):S15\u201322. https:\/\/doi.org\/10.3747\/co.23.2893.","journal-title":"Curr Oncol"},{"key":"420_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/cancers13020330","volume":"13","author":"C Andradas","year":"2021","unstructured":"Andradas C, Byrne J, Kuchibhotla M, et al. Assessment of cannabidiol and D9-tetrahydrocannabiol in mouse models of medulloblastoma and ependymoma. Cancers. 2021;13:330. https:\/\/doi.org\/10.3390\/cancers13020330.","journal-title":"Cancers"},{"key":"420_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/cells10030621","volume":"10","author":"K Biserova","year":"2021","unstructured":"Biserova K, Jakovlevs A, Uljanovs R, Strumfa I. Cancer Stem Cells: significance in origin, pathogenesis and treatment of glioblastoma. Cells. 2021;10:621.","journal-title":"Cells"},{"key":"420_CR22","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms22083863","volume":"22","author":"V Mattei","year":"2021","unstructured":"Mattei V, Santilli F, Martellucci S, et al. The importance of tumor stem cells in glioblastoma resistance to therapy. Int J Mol Sci. 2021;22:3863. https:\/\/doi.org\/10.3390\/ijms22083863.","journal-title":"Int J Mol Sci"},{"key":"420_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bcp.2018.09.007","volume":"157","author":"I Lopez-Valero","year":"2018","unstructured":"Lopez-Valero I, Saiz-Ladera C, Torres S, et al. Targeting glioma initiating cells with a combined therapy of cannabinoids and temozolomide. Biochem Pharmacol. 2018;157:266\u201374. https:\/\/doi.org\/10.1016\/j.bcp.2018.09.007.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"420_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.566","volume":"6","author":"E Singer","year":"2015","unstructured":"Singer E, Judkins J, Salomonis N, et al. Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma. Cell Death Dis. 2015;6(1): e1601. https:\/\/doi.org\/10.1038\/cddis.2014.566.","journal-title":"Cell Death Dis"},{"issue":"20","key":"420_CR25","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.3390\/molecules25204682","volume":"25","author":"R Schoeman","year":"2020","unstructured":"Schoeman R, Beukes N, Frost C. Cannabinoid combination induces cytoplasmic vacuolation in MCF-7 breast cancer cells. Molecules. 2020;25(20):4682. https:\/\/doi.org\/10.3390\/molecules25204682.","journal-title":"Molecules"},{"issue":"6","key":"420_CR26","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/jid.2015.45","volume":"135","author":"JL Armstrong","year":"2015","unstructured":"Armstrong JL, Hill DS, McKee CS, et al. Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. J Invest Dermatol. 2015;135(6):1629\u201337. https:\/\/doi.org\/10.1038\/jid.2015.45.","journal-title":"J Invest Dermatol"},{"key":"420_CR27","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3390\/cancers13071720","volume":"13","author":"H Peeri","year":"2021","unstructured":"Peeri H, Shalev N, Vinayaka AC, et al. Specific compositions of Cannabis sativa compounds have cytotoxic activity and inhibit motility and colony formation of human glioblastoma cells in vitro. Cancers. 2021;13:1720. https:\/\/doi.org\/10.3390\/cancers13071720.","journal-title":"Cancers"},{"key":"420_CR28","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1093\/carcin\/bgu205","volume":"35","author":"F Borrelli","year":"2014","unstructured":"Borrelli F, Pagano E, Romano B, et al. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Carcinogenesis. 2014;35:2787\u201397. https:\/\/doi.org\/10.1093\/carcin\/bgu205.","journal-title":"Carcinogenesis"},{"issue":"1","key":"420_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3892\/ijo.2017.4022","volume":"51","author":"KA Scott","year":"2017","unstructured":"Scott KA, Dalgleish AG, Liu WM. Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia can be improved by altering the sequence of their administration. Int J Oncol. 2017;51(1):369\u201377. https:\/\/doi.org\/10.3892\/ijo.2017.4022.","journal-title":"Int J Oncol"},{"key":"420_CR30","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3389\/fphar.2019.01198","volume":"10","author":"H Neumann-Raizel","year":"2019","unstructured":"Neumann-Raizel H, Shilo A, Lev S, et al. 2-APB and CBD-mediated targeting of charged cytotoxic compounds into tumor-like cells suggests the involvement of TRPV2 channels. Front Pharmacol. 2019;10:1198. https:\/\/doi.org\/10.3389\/fphar.2019.01198.","journal-title":"Front Pharmacol"},{"issue":"1","key":"420_CR31","doi-asserted-by":"publisher","first-page":"20622","DOI":"10.1038\/s41598-020-77674-y","volume":"10","author":"YY Go","year":"2020","unstructured":"Go YY, Kim SR, Kim DY, et al. Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Nat Res Sci Rep. 2020;10(1):20622. https:\/\/doi.org\/10.1038\/s41598-020-77674-y.","journal-title":"Nat Res Sci Rep."},{"issue":"11","key":"420_CR32","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1080\/15548627.2021.1885203","volume":"17","author":"T Huang","year":"2021","unstructured":"Huang T, Xu T, Wang Y, et al. Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. Autophagy. 2021;17(11):3592\u2013606. https:\/\/doi.org\/10.1080\/15548627.2021.1885203.","journal-title":"Autophagy"},{"issue":"1","key":"420_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2020.100774","volume":"79","author":"P Malhotra","year":"2021","unstructured":"Malhotra P, Casari I, Falasca M. Therapeutic potential of cannabinoids in combination cancer therapy. Adv Biol Regul. 2021;79(1): 100774. https:\/\/doi.org\/10.1016\/j.jbior.2020.100774.","journal-title":"Adv Biol Regul."},{"key":"420_CR34","doi-asserted-by":"publisher","unstructured":"Tomko AM, Whynot EG, Dupr\u00e9 DJ. Anti-cancer properties of cannabidiol and \u22069-tetrahydrocannabinol and potential synergistic effects with gemcitabine, cisplatin and other cannabinoids in bladder cancer. BioRxiv. Preprint 25 Mar 2021. doi:https:\/\/doi.org\/10.1101\/2021.03.25.436633.","DOI":"10.1101\/2021.03.25.436633"},{"issue":"43","key":"420_CR35","doi-asserted-by":"publisher","first-page":"74068","DOI":"10.18632\/oncotarget.18240","volume":"8","author":"VN Ivanov","year":"2017","unstructured":"Ivanov VN, Wu J, Hei TK. Regulation of human glioblastoma cell death by combined treatment of cannabidiol, \u03b3-radiation and small molecule inhibitors of cell signaling pathways. Oncotarget. 2017;8(43):74068\u201395. https:\/\/doi.org\/10.18632\/oncotarget.18240.","journal-title":"Oncotarget"},{"issue":"10","key":"420_CR36","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1080\/1042819031000103917","volume":"44","author":"R Gallily","year":"2003","unstructured":"Gallily R, Even-Chena T, Katzavian G, Lehmann D, Dagan A, Mechoulam R. Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells. Leuk Lymphoma. 2003;44(10):1767\u201373.","journal-title":"Leuk Lymphoma"},{"key":"420_CR37","doi-asserted-by":"publisher","first-page":"070","DOI":"10.24966\/ACIM-7562\/100066","volume":"5","author":"G Nahler","year":"2019","unstructured":"Nahler G, Jones T, Russo EB. Cannabidiol and contributions of major hemp phytocompounds to the \u201cEntourage Effect\u201d: possible mechanisms. J Altern Complement Integr Med. 2019;5:070. https:\/\/doi.org\/10.24966\/ACIM-7562\/100066.","journal-title":"J Altern Complement Integr Med."},{"issue":"1","key":"420_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1089\/can.2018.0065","volume":"3","author":"WM Raup-Konsavage","year":"2018","unstructured":"Raup-Konsavage WM, Johnson M, Legare CA, et al. Synthetic cannabinoid activity against colorectal cancer cells. Cannabis Cannabinoid Res. 2018;3(1):272\u201381. https:\/\/doi.org\/10.1089\/can.2018.0065.","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"420_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12906-016-1280-0","volume":"16","author":"ST Lukhele","year":"2016","unstructured":"Lukhele ST, Motadi LR. Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells. BMC Complement Altern Med. 2016;16(1):335. https:\/\/doi.org\/10.1186\/s12906-016-1280-0.","journal-title":"BMC Complement Altern Med"},{"key":"420_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bcp.2018.06.025","volume":"157","author":"S Blasco-Benito","year":"2018","unstructured":"Blasco-Benito S, Seijo-Vila M, Caro-Villalobos M, et al. Appraising the \u201centourage effect\u201d: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochem Pharmacol. 2018;157:285\u201393. https:\/\/doi.org\/10.1016\/j.bcp.2018.06.025.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"420_CR41","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1055\/s-0031-1298334","volume":"78","author":"M Eichler","year":"2012","unstructured":"Eichler M, Spinedi L, Unfer-Grauwiler S, et al. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects. Planta Med. 2012;78(7):686\u201391. https:\/\/doi.org\/10.1055\/s-0031-1298334.","journal-title":"Planta Med"},{"issue":"10","key":"420_CR42","first-page":"4373","volume":"33","author":"KA Scott","year":"2013","unstructured":"Scott KA, Shah S, Dalgleish AG, Liu WM. Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules. Anticancer Res. 2013;33(10):4373\u201380.","journal-title":"Anticancer Res"},{"issue":"1","key":"420_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1089\/pancan.2020.0003","volume":"6","author":"A Aizikovich","year":"2020","unstructured":"Aizikovich A. Anticancer effect of new cannabinoids derived from tetrahydrocannabinolic acid on PANC-1 and AsPC-1 human pancreas tumor cells. J Pancreatic Cancer. 2020;6(1):40\u20134. https:\/\/doi.org\/10.1089\/pancan.2020.0003.","journal-title":"J Pancreatic Cancer"},{"issue":"17","key":"420_CR44","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.3390\/molecules24173031","volume":"24","author":"D Namdar","year":"2019","unstructured":"Namdar D, Voet H, Ajjampura V, et al. Terpenoids and phytocannabinoids co-produced in cannabis sativa strains show specific interaction for cell cytotoxic activity. Molecules. 2019;24(17):3031. https:\/\/doi.org\/10.3390\/molecules24173031.","journal-title":"Molecules"},{"key":"420_CR45","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1021\/acs.jnatprod.5b00065","volume":"78","author":"MM Radwan","year":"2015","unstructured":"Radwan MM, ElSohly MA, El-Alfy AT, et al. Isolation and pharmacological evaluation of minor cannabinoids from high-potency Cannabis sativa. J Nat Prod. 2015;78:1271\u20136. https:\/\/doi.org\/10.1021\/acs.jnatprod.5b00065.","journal-title":"J Nat Prod"},{"key":"420_CR46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/molecules26020465","volume":"26","author":"O Anis","year":"2021","unstructured":"Anis O, Vinayaka AC, Shalev J, et al. Cannabis-derived compounds cannabichromene and D9-tetrahydrocannabinol interact and exhibit cytotoxic activity against urothelial cell carcinoma correlated with inhibition of cell migration and cytoskeleton organization. Molecules. 2021;26:465. https:\/\/doi.org\/10.3390\/molecules26020465.","journal-title":"Molecules"},{"key":"420_CR47","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/s41598-020-59468-4","volume":"10","author":"VN Ivanov","year":"2020","unstructured":"Ivanov VN, Grabham PW, Wu CC, Hei TK. Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures. Sci Rep. 2020;10:2687. https:\/\/doi.org\/10.1038\/s41598-020-59468-4.","journal-title":"Sci Rep"},{"issue":"3","key":"420_CR48","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1159\/000356446","volume":"6","author":"Y Singh","year":"2013","unstructured":"Singh Y, Bali C. Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation. Case Rep Oncol. 2013;6(3):585\u201392. https:\/\/doi.org\/10.1159\/000356446.","journal-title":"Case Rep Oncol"},{"issue":"3","key":"420_CR49","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/s0014-5793(03)01349-8","volume":"555","author":"MG Sanchez","year":"2003","unstructured":"Sanchez MG, Sanchez AM, Ruiz-Llorente L, Diaz-Laviada I. Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells. FEBS Lett. 2003;555(3):561\u20136. https:\/\/doi.org\/10.1016\/s0014-5793(03)01349-8.","journal-title":"FEBS Lett"},{"key":"420_CR50","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1158\/1078-0432.CCR-18-3301","volume":"26","author":"C Liu","year":"2020","unstructured":"Liu C, Sadat SH, Ebisumoto K, et al. Cannabinoids promote progression of HPV-positive head and neck squamous cell carcinoma via p38 MAPK activation. Clin Cancer Res. 2020;26:2693\u2013703. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3301.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"420_CR51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4049\/jimmunol.165.1.373","volume":"165","author":"LX Zhu","year":"2000","unstructured":"Zhu LX, Sharma S, Stolina M, et al. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol. 2000;165(1):373\u201380. https:\/\/doi.org\/10.4049\/jimmunol.165.1.373.","journal-title":"J Immunol"},{"issue":"6","key":"420_CR52","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","volume":"174","author":"RJ McKallip","year":"2005","unstructured":"McKallip RJ, Nagarkatti M, Nagarkatti PS. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol. 2005;174(6):3281\u20139. https:\/\/doi.org\/10.4049\/jimmunol.174.6.3281.","journal-title":"J Immunol"},{"key":"420_CR53","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.2147\/CMAR.S181272","volume":"10","author":"J Wu","year":"2018","unstructured":"Wu J, Zhang J, Jiang M, Zhang T, Wang Y, Wang Z, et al. Comparison between NOD\/SCID mice and BALB\/c mice for patient-derived tumor xenografts model of non-small-cell lung cancer. Cancer Manag Res. 2018;10:6695\u2013703.","journal-title":"Cancer Manag Res"},{"key":"420_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/1874226200902010079","volume":"2","author":"JE Belizario","year":"2009","unstructured":"Belizario JE. Immunodeficient mouse models: an overview. Open Immunol J. 2009;2:79\u201385.","journal-title":"Open Immunol J"},{"key":"420_CR55","doi-asserted-by":"publisher","unstructured":"Omer S, Boothe D, Mansour M, et al. Anti-proliferative effect of cannabidiol (CBD) against B and T-cell lymphoma [abstract]. Proceedings of the AACR Virtual Special Conference on Tumor Heterogeneity: From Single Cells to Clinical Impact; 2020 Sep 17-18: Philadelphia (PA); AACR; Cancer Res 2020;80(21 Suppl):abstract no. PO-047. doi: https:\/\/doi.org\/10.1158\/1538-7445.TUMHET2020-PO-047","DOI":"10.1158\/1538-7445.TUMHET2020-PO-047"},{"issue":"8","key":"420_CR56","doi-asserted-by":"publisher","first-page":"E302","DOI":"10.3390\/biom9080302","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang X, Qin Y, Pan Z, et al. Cannabidiol induces cell cycle arrest and cell apoptosis in human gastric cancer SGC-7901 cells. Biomolecules. 2019;9(8):E302. https:\/\/doi.org\/10.3390\/biom9080302.","journal-title":"Biomolecules"},{"issue":"1","key":"420_CR57","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1535-7163.MCT-10-0688","volume":"10","author":"S Torres","year":"2011","unstructured":"Torres S, Lorente M, Rodriguez-Fornes F, et al. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol Cancer Ther. 2011;10(1):90\u2013103. https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0688.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"420_CR58","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00109-011-0856-x","volume":"90","author":"G Aviello","year":"2012","unstructured":"Aviello G, Romano B, Borrelli F, et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med. 2012;90(8):925\u201334.","journal-title":"J Mol Med"},{"issue":"5","key":"420_CR59","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.phymed.2013.11.006","volume":"21","author":"B Romano","year":"2014","unstructured":"Romano B, Borrelli F, Pagano E, et al. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. Phytomedicine. 2014;21(5):631\u20139. https:\/\/doi.org\/10.1016\/j.phymed.2013.11.006.","journal-title":"Phytomedicine"},{"key":"420_CR60","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","volume":"9","author":"M Elbaz","year":"2015","unstructured":"Elbaz M, Nasser MW, Ravi J, et al. Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer. Mol Oncol. 2015;9:906\u201319. https:\/\/doi.org\/10.1016\/j.molonc.2014.12.010.","journal-title":"Mol Oncol"},{"key":"420_CR61","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1111\/bph.12803","volume":"171","author":"R Murase","year":"2014","unstructured":"Murase R, Kawamura R, Singer E, et al. Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Br J Pharmacol. 2014;171:4464\u201377. https:\/\/doi.org\/10.1111\/bph.12803.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"420_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1158\/1535-7163.MCT-12-0335","volume":"12","author":"R Ramer","year":"2013","unstructured":"Ramer R, Heinemann K, Merkord J, et al. COX-2 and PPAR-gamma confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther. 2013;12(1):69\u201382. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0335.","journal-title":"Mol Cancer Ther"},{"key":"420_CR63","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jss.2018.08.055","volume":"235","author":"E Simmerman","year":"2019","unstructured":"Simmerman E, Qin X, Yu JC, Baban B. Cannabinoids as a potential new and novel treatment for melanoma: a pilot study in a murine model. J Surg Res. 2019;235:210\u20135. https:\/\/doi.org\/10.1016\/j.jss.2018.08.055.","journal-title":"J Surg Res"},{"issue":"5","key":"420_CR64","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1158\/0008-5472.can-12-1943","volume":"73","author":"L Soroceanu","year":"2013","unstructured":"Soroceanu L, Murase R, Limbad C, et al. Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target. Cancer Res. 2013;73(5):1559\u201369. https:\/\/doi.org\/10.1158\/0008-5472.can-12-1943.","journal-title":"Cancer Res"},{"key":"420_CR65","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1038\/s41388-018-0390-1","volume":"37","author":"R Ferro","year":"2018","unstructured":"Ferro R, Adamska A, Lattanzio R, et al. GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. Oncogene. 2018;37:6368\u201382. https:\/\/doi.org\/10.1038\/s41388-018-0390-1.","journal-title":"Oncogene"},{"issue":"3","key":"420_CR66","first-page":"1","volume":"31","author":"JW Shin","year":"2010","unstructured":"Shin JW, Seol IC, Son CG. Interpretation of animal dose and human equivalent dose for drug development. J Korean Orient Med. 2010;31(3):1\u20137.","journal-title":"J Korean Orient Med"},{"key":"420_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharma. 2016;7:27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703.","journal-title":"J Basic Clin Pharma"},{"issue":"3","key":"420_CR68","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/73171","volume":"6","author":"I Galve-Roperh","year":"2000","unstructured":"Galve-Roperh I, Sanchez C, Cortes ML, et al. Antitumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med. 2000;6(3):313\u20139. https:\/\/doi.org\/10.1038\/73171.","journal-title":"Nat Med"},{"key":"420_CR69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s42238-021-00069-x","volume":"3","author":"MA Zenone","year":"2021","unstructured":"Zenone MA, Snyder J, Crooks VA. What are the informational pathways that shape people\u2019s use of cannabidiol for medical purposes? J Cannabis Res. 2021;3:13. https:\/\/doi.org\/10.1186\/s42238-021-00069-x.","journal-title":"J Cannabis Res."},{"key":"420_CR70","unstructured":"Kander J. Cannabis for the treatment of cancer. The anticancer activity of phytocannabinoids and endocannabinoids. 7th ed. Kindle Edition; 2021."},{"issue":"8","key":"420_CR71","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1158\/1940-6207.CAPR-09-0048","volume":"2","author":"C Liang","year":"2009","unstructured":"Liang C, McClean MD, Marsit C, et al. A population-based case-control study of marijuana use and head and neck squamous cell carcinoma. Cancer Prev Res (Phila). 2009;2(8):759\u201368. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-09-0048.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"420_CR72","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3747\/co.25.3983","volume":"25","author":"K Martell","year":"2018","unstructured":"Martell K, Fairchild A, LeGerrier B, et al. Rates of cannabis use in patients with cancer. Curr Oncol. 2018;25(3):219\u201325. https:\/\/doi.org\/10.3747\/co.25.3983.","journal-title":"Curr Oncol"},{"issue":"22","key":"420_CR73","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1002\/cncr.30879","volume":"123","author":"SA Pergam","year":"2017","unstructured":"Pergam SA, Woodfield MC, Lee CM, et al. Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer. 2017;123(22):4488\u201397. https:\/\/doi.org\/10.1002\/cncr.30879.","journal-title":"Cancer"},{"key":"420_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1200\/JCO.2021.39.15_suppl.12096","volume":"28","author":"CM Baily-Dorton","year":"2021","unstructured":"Baily-Dorton CM, Gentile D, Boselli D, et al. Cannabidiol (CBD) use among cancer survivors. J Clin Oncol. 2021;28:39. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.12096.","journal-title":"J Clin Oncol"},{"key":"420_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102688","volume":"77","author":"T Tran","year":"2020","unstructured":"Tran T, Kavuluru R. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products. Int J Drug Policy. 2020;77: 102688. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102688.","journal-title":"Int J Drug Policy"},{"key":"420_CR76","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.21873\/anticanres.12924","volume":"38","author":"J Kenyon","year":"2018","unstructured":"Kenyon J, Liu W, Dalgleish A. Report of objective clinical responses of cancer patients to pharmaceutical-grade synthetic cannabidiol. Anticancer Res. 2018;38:5831\u20135. https:\/\/doi.org\/10.21873\/anticanres.12924.","journal-title":"Anticancer Res"},{"key":"420_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.21873\/cdp.10011","volume":"1","author":"R Likar","year":"2021","unstructured":"Likar R, Koestenberger M, Stutschnig M, Nahler G. Cannabidiol may prolong survival in patients with glioblastoma multiforme. Cancer Diagn Progn. 2021;1:77\u201382. https:\/\/doi.org\/10.21873\/cdp.10011.","journal-title":"Cancer Diagn Progn"},{"key":"420_CR78","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.21873\/anticanres.13783","volume":"39","author":"R Likar","year":"2019","unstructured":"Likar R, Koestenberger M, Stultschnig M, Nahler G. Concomitant treatment of malignant brain tumours with CBD \u2013 a case series and review of the literature. Anticancer Res. 2019;39:5797\u2013801. https:\/\/doi.org\/10.21873\/anticanres.13783.","journal-title":"Anticancer Res"},{"key":"420_CR79","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fonc.2018.00643","volume":"8","author":"PB Dall Stella","year":"2019","unstructured":"Dall Stella PB, Docema MFL, Maldaun MVC, et al. Case report: Clinical outcome and image response of two patients with secondary high-grade glioma treated with chemoradiation, PCV, and cannabidiol. Front Oncol. 2019;8:643. https:\/\/doi.org\/10.3389\/fonc.2018.00643.","journal-title":"Front Oncol"},{"key":"420_CR80","doi-asserted-by":"publisher","DOI":"10.31487\/j.COR.2020.08.18","author":"R Likar","year":"2020","unstructured":"Likar R, Nahler G. Cannabidiol possibly improves survival of patients with pancreatic cancer: A case series. Clin Oncol Res. 2020. https:\/\/doi.org\/10.31487\/j.COR.2020.08.18.","journal-title":"Clin Oncol Res."},{"key":"420_CR81","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2019.11.002","volume":"125","author":"AEJ Latenstein","year":"2020","unstructured":"Latenstein AEJ, van der Geest LGM, Bonsing BA, et al. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer. 2020;125:83\u201393. https:\/\/doi.org\/10.1016\/j.ejca.2019.11.002.","journal-title":"Eur J Cancer"},{"key":"420_CR82","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.gore.2019.05.004","volume":"29","author":"AM Barrie","year":"2019","unstructured":"Barrie AM, Cushue AC, Eskander RN. Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinoma. Gynecologic Oncol Reports. 2019;29:10\u20132. https:\/\/doi.org\/10.1016\/j.gore.2019.05.004.","journal-title":"Gynecologic Oncol Reports"},{"key":"420_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2050313X19832160","volume":"7","author":"J Sul\u00e9-Suso","year":"2019","unstructured":"Sul\u00e9-Suso J, Watson NA, van Pittius DG, Jegannathen A. Striking lung cancer response to self-administration of cannabidiol: a case report and literature review. SAGE Open Med Case Rep. 2019;7:1\u20134. https:\/\/doi.org\/10.1177\/2050313X19832160.","journal-title":"SAGE Open Med Case Rep"},{"issue":"1","key":"420_CR84","first-page":"1","volume":"6","author":"ZZ Cernovsky","year":"2019","unstructured":"Cernovsky ZZ, Litman LC. Case studies of analgesic cannabinoid use by persons with chronic pain from car accidents. Open Sci J Psychol. 2019;6(1):1\u20134.","journal-title":"Open Sci J Psychol"},{"issue":"10","key":"420_CR85","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244195","volume":"14","author":"KL Liew","year":"2021","unstructured":"Liew KL, Capuano E, Yung B. Lung cancer patient who had declined conventional cancer treatment: could the self-administration of \u2018CBD oil\u2019 be contributing to the observed tumour regression? BMJ Case Rep. 2021;14(10): e244195. https:\/\/doi.org\/10.1136\/bcr-2021-244195.","journal-title":"BMJ Case Rep"},{"issue":"6","key":"420_CR86","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/cap.2020.0203","volume":"31","author":"CM Klier","year":"2021","unstructured":"Klier CM, Amminger GP, Kothgassner OD, et al. Letter to the Editor: Cannabidiol Treatment\u2014is there an effect on cognitive functioning, quality of life and behavior? A case Report. J Child Adolesc Psychopharmacol. 2021;31(6):447\u20139. https:\/\/doi.org\/10.1089\/cap.2020.0203.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"420_CR87","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.bjc.6603236","volume":"95","author":"M Guzman","year":"2006","unstructured":"Guzman M, Duarte MJ, Blazquez C, et al. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95:197\u2013203. https:\/\/doi.org\/10.1038\/sj.bjc.6603236.","journal-title":"Br J Cancer"},{"key":"420_CR88","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"issue":"15","key":"420_CR89","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1200\/JCO.2017.35.15_suppl.2046","volume":"35","author":"C Twelves","year":"2017","unstructured":"Twelves C, Short S, Wright S. A two-part safety and exploratory efficacy randomized double-blind, placebo-controlled study of a 1:1 ratio of the cannabinoids cannabidiol and delta-9-tetrahydrocannabinol (CBD:THC) plus dose-intense temozolomide in patients with recurrent glioblastoma multiforme (GBM). J Clin Oncol. 2017;35(15):2046. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.2046.","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"420_CR90","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1182\/blood-2019-126693","volume":"134","author":"CM Melen","year":"2019","unstructured":"Melen CM, Merrien M, Wasik A, Sonnevi K, Junlen HR, Christersson B, Sander B, Wahlin BE. A clinical trial of cannabis as targeted therapy for indolent leukemic lymphoma. Blood. 2019;134(Suppl. 1):5487. https:\/\/doi.org\/10.1182\/blood-2019-126693.","journal-title":"Blood"},{"key":"420_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105651","volume":"169","author":"J Aviram","year":"2021","unstructured":"Aviram J, Lewitus GM, Pud D, et al. Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis. Pharmacol Res. 2021;169: 105651. https:\/\/doi.org\/10.1016\/j.phrs.2021.105651.","journal-title":"Pharmacol Res"},{"key":"420_CR92","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.3390\/ijms21228870","volume":"21","author":"J Mlost","year":"2020","unstructured":"Mlost J, Bryk M, Starowicz K. Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int J Mol Sci. 2020;21:8870. https:\/\/doi.org\/10.3390\/ijms21228870.","journal-title":"Int J Mol Sci"},{"key":"420_CR93","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1111\/j.1476-5381.2011.01461.x","volume":"165","author":"A Juknat","year":"2012","unstructured":"Juknat A, Pietr M, Kozela E, et al. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and D9-tetrahydrocannabinol in BV-2 microglial cells. Br J Pharmacol. 2012;165:2512\u201328. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01461.x.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"420_CR94","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.3390\/cancers12113203","volume":"12","author":"ES Seltzer","year":"2020","unstructured":"Seltzer ES, Watters AK, MacKenzie D, et al. Cannabidiol (CBD) as a promising anti-cancer drug. Cancers (Basel). 2020;12(11):3203. https:\/\/doi.org\/10.3390\/cancers12113203.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"420_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.471","volume":"4","author":"N Rimmerman","year":"2013","unstructured":"Rimmerman N, Ben-Hail D, Porat Z, et al. Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death. Cell Death Dis. 2013;4(12): e949. https:\/\/doi.org\/10.1038\/cddis.2013.471.","journal-title":"Cell Death Dis"},{"issue":"1\u20133","key":"420_CR96","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejphar.2013.08.039","volume":"718","author":"B Adinolfi","year":"2013","unstructured":"Adinolfi B, Romanini A, Vanni A, et al. Anticancer activity of anandamide in human cutaneous melanoma cells. Eur J Pharmacol. 2013;718(1\u20133):154\u20139. https:\/\/doi.org\/10.1016\/j.ejphar.2013.08.039.","journal-title":"Eur J Pharmacol"},{"issue":"41","key":"420_CR97","doi-asserted-by":"publisher","first-page":"31938","DOI":"10.1074\/jbc.M005722200","volume":"275","author":"M Maccarrone","year":"2000","unstructured":"Maccarrone M, Lorenzon T, Bari M, et al. Anandamide induces apoptosis in human cells via vanilloid receptors. J Biol Chem. 2000;275(41):31938\u201345. https:\/\/doi.org\/10.1074\/jbc.M005722200.","journal-title":"J Biol Chem"},{"key":"420_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108952","volume":"115","author":"C Qiu","year":"2019","unstructured":"Qiu C, Yang L, Wang B, et al. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer. Biomed Pharmacother. 2019;115: 108952. https:\/\/doi.org\/10.1016\/j.biopha.2019.108952.","journal-title":"Biomed Pharmacother"},{"key":"420_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pros.10190","volume":"56","author":"M Mimeault","year":"2003","unstructured":"Mimeault M, Pommery N, Wattez N, et al. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines. Prostate. 2003;56:1\u201312. https:\/\/doi.org\/10.1002\/pros.10190.","journal-title":"Prostate"},{"key":"420_CR100","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3892\/or.2015.3746","volume":"33","author":"O Orellana-Serradell","year":"2015","unstructured":"Orellana-Serradell O, Poblete CE, Sanchez C, et al. Proapoptotic effect of endocannabinoids in prostate cancer cells. Oncol Rep. 2015;33:1599\u2013608. https:\/\/doi.org\/10.3892\/or.2015.3746.","journal-title":"Oncol Rep"},{"key":"420_CR101","doi-asserted-by":"publisher","first-page":"13543","DOI":"10.1073\/pnas.2230238100","volume":"100","author":"S Fong","year":"2003","unstructured":"Fong S, Itahana Y, Sumida T, et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci U S A. 2003;100:13543\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"420_CR102","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.3390\/ijms22073680","volume":"22","author":"C Pagano","year":"2021","unstructured":"Pagano C, Navarra G, Coppola L, et al. Molecular mechanism of cannabinoids in cancer progression. Int J Mol Sci. 2021;22:3680. https:\/\/doi.org\/10.3390\/ijms22073680.","journal-title":"Int J Mol Sci"},{"key":"420_CR103","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/cells10061282","volume":"10","author":"M Braile","year":"2021","unstructured":"Braile M, Marcella S, Marone G, Galdiero MR, Varricchi G, Loffredo S. The interplay between the immune and the endocannabinoid systems in cancer. Cells. 2021;10:1282. https:\/\/doi.org\/10.3390\/cells10061282.","journal-title":"Cells"},{"issue":"1","key":"420_CR104","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1210\/jc.2014-3455","volume":"100","author":"EC Hanlon","year":"2015","unstructured":"Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, de Witt H, et al. Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. J Clin Endocrinol Metab. 2015;100(1):220\u20136. https:\/\/doi.org\/10.1210\/jc.2014-3455.","journal-title":"J Clin Endocrinol Metab"},{"key":"420_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104471","volume":"111","author":"EC Hanlon","year":"2020","unstructured":"Hanlon EC. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). Psychoneuroendocrinology. 2020;111: 104471. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104471.","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"420_CR106","doi-asserted-by":"publisher","first-page":"E1844","DOI":"10.3390\/ijms18091844","volume":"18","author":"I Bazwinsky-Wutschke","year":"2017","unstructured":"Bazwinsky-Wutschke I, Zipprich A, Dehghani F. Daytime-dependent changes of cannabinoid receptor type 1 and type 2 expression in rat liver. Int J Mol Sci. 2017;18(9):E1844. https:\/\/doi.org\/10.3390\/ijms18091844.","journal-title":"Int J Mol Sci"},{"key":"420_CR107","doi-asserted-by":"publisher","unstructured":"Faulkes S, Lockwood G, O\u2019Sullivan SE, Grundy RG, Storer LCD. Ther-03. In vitro evaluation of the effect of cannabidiol on paediatric brain tumour celllines using a pulsed treatment regime [abstract]. Neuro-Oncology 2020;22(3):iii471-iii472. doi:\u00a0https:\/\/doi.org\/10.1093\/neuonc\/noaa222.853. Available at: https:\/\/academic.oup.com\/neuro-oncology\/article\/22\/Supplement_3\/iii471\/6019336. Accessed 19 Dec 2020.","DOI":"10.1093\/neuonc\/noaa222.853"},{"key":"420_CR108","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1111\/bph.14331","volume":"175","author":"AI Fraguas-Sanchez","year":"2018","unstructured":"Fraguas-Sanchez AI, Martin-Sabroso C, Torres-Suarez AI. Insights into the effects of the endocannabinoid system in cancer: a review. Br J Pharmacol. 2018;175:2566\u201380. https:\/\/doi.org\/10.1111\/bph.14331.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"420_CR109","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.bcp.2009.11.007","volume":"79","author":"R Ramer","year":"2010","unstructured":"Ramer R, Merkord J, Rohde H, Hinz B. Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of Matrix Metalloproteinases-1. Biochem Pharmacol. 2010;79(7):955\u201366. https:\/\/doi.org\/10.1016\/j.bcp.2009.11.007.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"420_CR110","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12885-017-3896-y","volume":"18","author":"CS Goldsmith","year":"2018","unstructured":"Goldsmith CS, Kim SM, Karunarathna N, et al. Inhibition of p38 MAPK activity leads to cell type-specific effects on the molecular circadian clock and time-dependent reduction of glioma cell invasiveness. BMC Cancer. 2018;18(1):43. https:\/\/doi.org\/10.1186\/s12885-017-3896-y.","journal-title":"BMC Cancer"},{"issue":"5","key":"420_CR111","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1470-2045(00)00326-0","volume":"2","author":"F Levi","year":"2001","unstructured":"Levi F. Circadian chronotherapy for human cancers. Lancet Oncol. 2001;2(5):307\u201315. https:\/\/doi.org\/10.1016\/S1470-2045(00)00326-0.","journal-title":"Lancet Oncol"},{"issue":"9079","key":"420_CR112","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/s0140-6736(97)03358-8","volume":"350","author":"F Levi","year":"1997","unstructured":"Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet. 1997;350(9079):681\u20136. https:\/\/doi.org\/10.1016\/s0140-6736(97)03358-8.","journal-title":"Lancet"},{"issue":"2","key":"420_CR113","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001753R","volume":"35","author":"PM Wagner","year":"2021","unstructured":"Wagner PM, Prucca CG, Velazquez FN, et al. Temporal regulation of tumor growth in nocturnal mammals: in vivo studies and chemotherapeutical potential. FASEB J. 2021;35(2): e21231. https:\/\/doi.org\/10.1096\/fj.202001753R.","journal-title":"FASEB J"},{"issue":"2","key":"420_CR114","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1096\/fj.04-2665fje","volume":"19","author":"TG Granda","year":"2005","unstructured":"Granda TG, Liu XH, Rune Smaaland R, et al. Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumor. FASEB J. 2005;19(2):304\u20136. https:\/\/doi.org\/10.1096\/fj.04-2665fje.","journal-title":"FASEB J"},{"issue":"1","key":"420_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/noajnl\/vdab041","volume":"3","author":"AR Damato","year":"2021","unstructured":"Damato AR, Luo J, Katumba RGN, et al. Temozolomide chronotherapy in patients with glioblastoma: a retrospective review. Neuro-Oncol Adv. 2021;3(1):1\u201311. https:\/\/doi.org\/10.1093\/noajnl\/vdab041.","journal-title":"Neuro-Oncol Adv"},{"issue":"6","key":"420_CR116","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1089\/can.2020.0166","volume":"6","author":"KG Wagoner","year":"2021","unstructured":"Wagoner KG, Lazard AJ, Romero-Sandoval A, Reboussin BA. Health claims about cannabidiol products: A retrospective analysis of US Food and Drug Administration warning letters from 2015 to 2019. Cannabis Cannabinoid Res. 2021;6(6):559\u201363. https:\/\/doi.org\/10.1089\/can.2020.0166.","journal-title":"Cannabis Cannabinoid Res."},{"issue":"8","key":"420_CR117","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1503\/cmaj.150847","volume":"188","author":"AM Li","year":"2016","unstructured":"Li AM, Rassekh SR. Hypotension associated with ingestion of cannabinoids in two children with cancer. CMAJ. 2016;188(8):596\u20137. https:\/\/doi.org\/10.1503\/cmaj.150847.","journal-title":"CMAJ"},{"issue":"9","key":"420_CR118","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.clinthera.2017.12.008","volume":"40","author":"CJ Lucas","year":"2018","unstructured":"Lucas CJ, Galettis P, Song S, et al. Cannabinoid disposition after human intraperitoneal use: An insight into intraperitoneal pharmacokinetic properties in metastatic cancer. Clin Ther. 2018;40(9):1442\u20137. https:\/\/doi.org\/10.1016\/j.clinthera.2017.12.008.","journal-title":"Clin Ther"},{"issue":"1","key":"420_CR119","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/082585971202800110","volume":"28","author":"JGC Hasselt","year":"2012","unstructured":"Hasselt JGC, Heuvel MM, Schellens JHM, et al. Severe cannabinoid intoxication in a patient with non-small-cell lung cancer. J Palliat Care. 2012;28(1):60\u20131. https:\/\/doi.org\/10.1177\/082585971202800110.","journal-title":"J Palliat Care"},{"key":"420_CR120","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/cancers12092447","volume":"12","author":"G Bar-Sela","year":"2020","unstructured":"Bar-Sela G, Cohen I, Campisi-Pinto S, et al. Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome. Cancers. 2020;12:2447. https:\/\/doi.org\/10.3390\/cancers12092447.","journal-title":"Cancers"},{"key":"420_CR121","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.3390\/ijms21155533","volume":"21","author":"D Cerretani","year":"2020","unstructured":"Cerretani D, Collodel G, Brizzi A, et al. Cytotoxic effects of cannabinoids on human HT-29 Colorectal adenocarcinoma cells: different mechanisms of THC, CBD, and CB83. Int J Mol Sci. 2020;21:5533. https:\/\/doi.org\/10.3390\/ijms21155533.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"420_CR122","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13105-018-0611-7","volume":"74","author":"BM Fonseca","year":"2018","unstructured":"Fonseca BM, Correia-da-Silva G, Teixeira NA. Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis. J Physiol Biochem. 2018;74(2):261\u201372. https:\/\/doi.org\/10.1007\/s13105-018-0611-7.","journal-title":"J Physiol Biochem"},{"issue":"21","key":"420_CR123","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.3390\/ijms21218035","volume":"21","author":"Y Yang","year":"2020","unstructured":"Yang Y, Huynh N, Dumesny C, et al. Cannabinoids inhibited pancreatic cancer via P-21 activated kinase 1 mediated pathway. Int J Mol Sci. 2020;21(21):8035. https:\/\/doi.org\/10.3390\/ijms21218035.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"420_CR124","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1158\/0008-5472.CAN-07-5176","volume":"68","author":"C Blazquez","year":"2008","unstructured":"Blazquez C, Salazar M, Carracedo A, et al. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Cancer Res. 2008;68(6):1945\u201352. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5176.","journal-title":"Cancer Res"},{"issue":"13","key":"420_CR125","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1158\/0008-5472.CAN-06-0169","volume":"66","author":"A Carracedo","year":"2006","unstructured":"Carracedo A, Gironella M, Lorente M, et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res. 2006;66(13):6748\u201355. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0169.","journal-title":"Cancer Res"},{"issue":"4","key":"420_CR126","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00381-011-1410-4","volume":"27","author":"M Foroughi","year":"2011","unstructured":"Foroughi M, Hendson G, Sargent MA, Steinbok P. Spontaneous regression of septum pellucidum\/forniceal pilocytic astrocytomas\u2014possible role of Cannabis inhalation. Childs Nerv Syst. 2011;27(4):671\u20139. https:\/\/doi.org\/10.1007\/s00381-011-1410-4.","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"420_CR127","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.jpainsymman.2016.09.003","volume":"53","author":"V Maida","year":"2017","unstructured":"Maida V. Medical Cannabis in the palliation of malignant wounds \u2013 a case report. J Pain Symptom Manag. 2017;53(1):e4\u20136. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.09.003.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"420_CR128","first-page":"11","volume":"26","author":"A Huniadi","year":"2021","unstructured":"Huniadi A, Sorian A, Iuhas C, et al. The effect of cannabis in the treatment of Hodgkin\u2019s lymphoma in a pregnant patient\u2014extensive case report and literature review. J BUON. 2021;26(1):11\u20136.","journal-title":"J BUON"}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-022-00420-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-022-00420-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-022-00420-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:08:48Z","timestamp":1650539328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40290-022-00420-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1007\/s40290-022-00420-4","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"29 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for publication of this review. The open access fee was paid by CIS Clinical Investigation Support GmbH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The author has no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Dr. Gerhard Nahler was the sole author of this article. He approved the final submitted manuscript and agrees to be accountable for the presented work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}}]}}